These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

622 related articles for article (PubMed ID: 22420752)

  • 1. Studies of H3K4me3 demethylation by KDM5B/Jarid1B/PLU1 reveals strong substrate recognition in vitro and identifies 2,4-pyridine-dicarboxylic acid as an in vitro and in cell inhibitor.
    Kristensen LH; Nielsen AL; Helgstrand C; Lees M; Cloos P; Kastrup JS; Helin K; Olsen L; Gajhede M
    FEBS J; 2012 Jun; 279(11):1905-14. PubMed ID: 22420752
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Catalytic properties and kinetic mechanism of human recombinant Lys-9 histone H3 methyltransferase SUV39H1: participation of the chromodomain in enzymatic catalysis.
    Chin HG; Patnaik D; Estève PO; Jacobsen SE; Pradhan S
    Biochemistry; 2006 Mar; 45(10):3272-84. PubMed ID: 16519522
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SUMOylation negatively modulates target gene occupancy of the KDM5B, a histone lysine demethylase.
    Bueno MT; Richard S
    Epigenetics; 2013 Nov; 8(11):1162-75. PubMed ID: 23970103
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of a Linked Jumonji Domain of the KDM5/JARID1 Family of Histone H3 Lysine 4 Demethylases.
    Horton JR; Engstrom A; Zoeller EL; Liu X; Shanks JR; Zhang X; Johns MA; Vertino PM; Fu H; Cheng X
    J Biol Chem; 2016 Feb; 291(6):2631-46. PubMed ID: 26645689
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Binding of the JmjC demethylase JARID1B to LSD1/NuRD suppresses angiogenesis and metastasis in breast cancer cells by repressing chemokine CCL14.
    Li Q; Shi L; Gui B; Yu W; Wang J; Zhang D; Han X; Yao Z; Shang Y
    Cancer Res; 2011 Nov; 71(21):6899-908. PubMed ID: 21937684
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structure of the Arabidopsis JMJ14-H3K4me3 Complex Provides Insight into the Substrate Specificity of KDM5 Subfamily Histone Demethylases.
    Yang Z; Qiu Q; Chen W; Jia B; Chen X; Hu H; He K; Deng X; Li S; Tao WA; Cao X; Du J
    Plant Cell; 2018 Jan; 30(1):167-177. PubMed ID: 29233856
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The histone-H3K4-specific demethylase KDM5B binds to its substrate and product through distinct PHD fingers.
    Klein BJ; Piao L; Xi Y; Rincon-Arano H; Rothbart SB; Peng D; Wen H; Larson C; Zhang X; Zheng X; Cortazar MA; Peña PV; Mangan A; Bentley DL; Strahl BD; Groudine M; Li W; Shi X; Kutateladze TG
    Cell Rep; 2014 Jan; 6(2):325-35. PubMed ID: 24412361
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of small molecule inhibitors of Jumonji AT-rich interactive domain 1B (JARID1B) histone demethylase by a sensitive high throughput screen.
    Sayegh J; Cao J; Zou MR; Morales A; Blair LP; Norcia M; Hoyer D; Tackett AJ; Merkel JS; Yan Q
    J Biol Chem; 2013 Mar; 288(13):9408-17. PubMed ID: 23408432
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The KDM5 family of histone demethylases as targets in oncology drug discovery.
    Rasmussen PB; Staller P
    Epigenomics; 2014 Jun; 6(3):277-86. PubMed ID: 25111482
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The PHD1 finger of KDM5B recognizes unmodified H3K4 during the demethylation of histone H3K4me2/3 by KDM5B.
    Zhang Y; Yang H; Guo X; Rong N; Song Y; Xu Y; Lan W; Zhang X; Liu M; Xu Y; Cao C
    Protein Cell; 2014 Nov; 5(11):837-50. PubMed ID: 24952722
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Histone demethylase lysine demethylase 5B in development and cancer.
    Han M; Xu W; Cheng P; Jin H; Wang X
    Oncotarget; 2017 Jan; 8(5):8980-8991. PubMed ID: 27974677
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The transcriptional repressor JHDM3A demethylates trimethyl histone H3 lysine 9 and lysine 36.
    Klose RJ; Yamane K; Bae Y; Zhang D; Erdjument-Bromage H; Tempst P; Wong J; Zhang Y
    Nature; 2006 Jul; 442(7100):312-6. PubMed ID: 16732292
    [TBL] [Abstract][Full Text] [Related]  

  • 13. KDM5B demethylates H3K4 to recruit XRCC1 and promote chemoresistance.
    Xu W; Zhou B; Zhao X; Zhu L; Xu J; Jiang Z; Chen D; Wei Q; Han M; Feng L; Wang S; Wang X; Zhou J; Jin H
    Int J Biol Sci; 2018; 14(9):1122-1132. PubMed ID: 29989047
    [TBL] [Abstract][Full Text] [Related]  

  • 14. KDM5B is a master regulator of the H3K4-methylome in stem cells, development and cancer.
    Xhabija B; Kidder BL
    Semin Cancer Biol; 2019 Aug; 57():79-85. PubMed ID: 30448242
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enzyme kinetic studies of histone demethylases KDM4C and KDM6A: towards understanding selectivity of inhibitors targeting oncogenic histone demethylases.
    Kristensen JB; Nielsen AL; Jørgensen L; Kristensen LH; Helgstrand C; Juknaite L; Kristensen JL; Kastrup JS; Clausen RP; Olsen L; Gajhede M
    FEBS Lett; 2011 Jun; 585(12):1951-6. PubMed ID: 21575637
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Overexpressed KDM5B is associated with the progression of glioma and promotes glioma cell growth via downregulating p21.
    Dai B; Hu Z; Huang H; Zhu G; Xiao Z; Wan W; Zhang P; Jia W; Zhang L
    Biochem Biophys Res Commun; 2014 Nov; 454(1):221-7. PubMed ID: 25450384
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of non-histone substrates for JMJD2A-C histone demethylases.
    Ponnaluri VK; Vavilala DT; Putty S; Gutheil WG; Mukherji M
    Biochem Biophys Res Commun; 2009 Dec; 390(2):280-4. PubMed ID: 19799855
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of the histone demethylase, KDM5B, directly induces re-expression of tumor suppressor protein HEXIM1 in cancer cells.
    Montano MM; Yeh IJ; Chen Y; Hernandez C; Kiselar JG; de la Fuente M; Lawes AM; Nieman MT; Kiser PD; Jacobberger J; Exner AA; Lawes MC
    Breast Cancer Res; 2019 Dec; 21(1):138. PubMed ID: 31805991
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Specificity and mechanism of JMJD2A, a trimethyllysine-specific histone demethylase.
    Couture JF; Collazo E; Ortiz-Tello PA; Brunzelle JS; Trievel RC
    Nat Struct Mol Biol; 2007 Aug; 14(8):689-95. PubMed ID: 17589523
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lysine demethylase 5B (KDM5B): A potential anti-cancer drug target.
    Zheng YC; Chang J; Wang LC; Ren HM; Pang JR; Liu HM
    Eur J Med Chem; 2019 Jan; 161():131-140. PubMed ID: 30343192
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 32.